What is the recommended starting dose of mirtazapine (Remeron) for an adult?

Starting Dose of Remeron (Mirtazapine)

The recommended starting dose of Remeron (mirtazapine) is 15 mg once daily, administered orally, preferably in the evening prior to sleep. 1

Dosing Algorithm

Standard Adult Dosing

• Initial dose: 15 mg once daily at bedtime 1
• Titration: If inadequate response after 1-2 weeks, increase to 30 mg daily 1
• Maximum dose: 45 mg per day 1
• Key principle: Dose changes should not be made in intervals less than 1-2 weeks to allow sufficient time for evaluation of response 1

Special Populations Requiring Dose Adjustment

Elderly patients (>65 years):

• Consider starting at 7.5 mg at bedtime 2
• Elderly patients show 27% higher drug concentrations compared to younger individuals 3
• More cautious titration is warranted due to increased pharmacokinetic variability

Women:

• Be aware that women exhibit 18% higher concentration-to-dose ratios than men 3
• Standard 15 mg starting dose applies, but monitor more closely for side effects

Hepatic or renal impairment:

• Start with lower doses and titrate carefully 1
• Close monitoring for adverse events is essential

Context-Specific Dosing

For depression with insomnia/anxiety (Alzheimer's disease, palliative care):

• Start at 7.5 mg at bedtime 2
• Maximum 30 mg at bedtime 2
• This lower starting dose is particularly useful when sedation and appetite stimulation are desired therapeutic effects

For gastrointestinal disorders (IBS, functional dyspepsia):

• Start at 15 mg once daily 4
• Maximum 45 mg once daily 4
• Recent evidence shows effectiveness for chronic GI pain with good tolerability

For neuropathic pain:

• No specific dosing mentioned in neuropathic pain guidelines 5, suggesting standard depression dosing applies

Important Clinical Considerations

Drug Interactions Requiring Dose Modification

Strong CYP3A4 inhibitors (ketoconazole, clarithromycin):

• Decrease mirtazapine dose 1
• Increase dose if inhibitor is discontinued

Strong CYP3A4 inducers (carbamazepine, phenytoin, rifampin):

• Increase mirtazapine dose 1
• Decrease dose if inducer is discontinued

Cimetidine:

• Decrease mirtazapine dose with concomitant use 1

Paroxetine co-administration:

• Reduces clearance by 26.9% 6
• Consider starting at 22.5-30 mg/day 6

Fluvoxamine co-administration:

• Reduces clearance by 51.1% 6
• Start at 15 mg/day 6

Common Pitfalls to Avoid

1. The sedation paradox: Sedation is actually more common at lower doses (due to H1 antagonism) and may decrease at higher therapeutic doses 7, 8. Don't assume increasing the dose will worsen sedation.

2. Premature dose escalation: Wait the full 1-2 weeks before increasing dose, as therapeutic effects may take 2-4 weeks to fully manifest 2

3. Obesity consideration: Patients with BMI ≥28 kg/m² have 29.4% reduced clearance 6. Consider starting at 22.5-30 mg/day in obese patients.

4. MAOI interactions: Must wait 14 days after discontinuing an MAOI before starting mirtazapine, and vice versa 1

Expected Side Effects at Starting Dose

The most common adverse effects are:

• Somnolence (23% vs 14% placebo) 1
• Increased appetite (11% vs 2% placebo) 1
• Weight gain (10% vs 1% placebo) 1
• Dry mouth (25% vs 16% placebo) 1

These effects can be therapeutic advantages in patients with depression-related insomnia, anorexia, or weight loss 2, 9.